- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04086914
Fascia Iliaca Compartment Blocks for Pain Control in Hip Fractures
February 4, 2020 updated by: Medical University of South Carolina
Fascia Iliaca Compartment Blocks to Improve Preoperative Pain Control in Elderly Hip Fractures
This study is comparing the use of a peripheral nerve block and standard opioid pain medications in pain control in hip fractures prior to surgery.
A peripheral nerve block is a procedure that injects numbing medicine around a nerve to help decrease the pain, motion, and sensation around the painful site temporarily.
The purpose of this study is to evaluate if peripheral nerve blocks are more effective for pain control than just standard opioid pain medication while decreasing the amount of side effects from opioid medication.
Study Overview
Study Type
Interventional
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 50 or older, low energy hip fracture, acute hip fracture
Exclusion Criteria:
- On anticoagulants, hardware present near injection site, preexisting nerve injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Non nerve block
Receives no nerve block
|
|
Experimental: Nerve block
Receives nerve block
|
This group will receive a nerve block consisting of 20mL of 5mg/mL ropivicanine and 0.1mL of 10mg'mL dexamethasone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Baseline Pain score on Visual analogue scale at initial encounter
Time Frame: 0-60 minutes
|
pain is measured 1-10, 1 being the lowest and 10 being the highest
|
0-60 minutes
|
Mean Change from baseline pain score on the visual analogue scale
Time Frame: 3-8 hours after initial encounter
|
pain is measured 1-10, 1 being the lowest and 10 being the highest
|
3-8 hours after initial encounter
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2020
Primary Completion (Anticipated)
November 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
September 10, 2019
First Submitted That Met QC Criteria
September 10, 2019
First Posted (Actual)
September 12, 2019
Study Record Updates
Last Update Posted (Actual)
February 6, 2020
Last Update Submitted That Met QC Criteria
February 4, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00090054
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Smith & Nephew, Inc.Terminated
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
Carilion ClinicCompleted
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
University of Missouri-ColumbiaUniversity of Alabama at Birmingham; Medical College of Wisconsin; University...CompletedHip Fractures | Pelvic Fractures | Acetabular FracturesUnited States
-
Rabin Medical CenterUnknown
-
Oslo University HospitalDiakonhjemmet HospitalCompletedHip Fractures | Trochanteric Fractures | Intertrochanteric FracturesNorway
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
Clinical Trials on Nerve Block
-
Severance HospitalRecruitingCough | Thoracic Surgery | Nerve BlockKorea, Republic of
-
Saint Francis CareCompleted
-
LifeBridge HealthRubin Institute for Advanced OrthopedicsRecruitingHip Osteoarthritis | Hip ArthropathyUnited States
-
Chicago Anesthesia Pain SpecialistsCompletedKnee ArthroplastyUnited States
-
University of California, San DiegoTerminatedFoot SurgeryUnited States
-
McGill University Health Centre/Research Institute...UnknownTotal Knee Arthroplasty Secondary to OsteoarthritisCanada
-
Seoul National University HospitalUnknownVideo Assisted Thoracoscopic SurgeryKorea, Republic of
-
Bagcilar Training and Research HospitalCompleted
-
Clinique Medipole GaronneCompletedPrimary Total Knee ArthroplastyFrance
-
University of AarhusPrivate Hospital MoelholmRecruitingHerniated Disc | Radiculopathy Lumbar | Stenosis, Spinal | Foraminal Stenosis | Radiculopathy SacralDenmark